Professional
Added to YB: 2025-12-05
Pitch date: 2025-10-30
DERM [neutral]
Journey Medical Corporation
-6%
current return
Author Info
No bio for this author
Company Info
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$201.1M
Pitch Price
$8.16
Price Target
20.00 (+161%)
Dividend
N/A
EV/EBITDA
-165.92
P/E
-19.72
EV/Sales
3.39
Sector
Pharmaceuticals
Category
growth
Summers Value Partners Portfolio Holding: Journey Medical Corporation
DERM (holding update): Dermatology co w/ new Emrosi rosacea treatment hitting $30M annualized sales in 6 months post-launch. Positive feedback suggests $100M+ peak sales potential. Profitable by 2026 via scalable model. Acquisition candidate amid industry consolidation. $20 price target.
Read full article (1 min)